Skip to main content
All lobbying filings

KAISER FOUNDATION HEALTH PLAN INC.

Lobbying for KAISER FOUNDATION HEALTH PLAN INC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $480,000.00 expenses · posted Jul 18, 2025

Official filing document

 Bills named in this filing 11
  • HR 247
    Health Care Affordability Act of 2025
  • S 46
    Health Care Affordability Act of 2025
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 527
    Prescription Pricing for the People Act of 2025
  • S 1040
    Drug Competition Enhancement Act
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • S 1095
    Stop STALLING Act
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
  • S 1553
    PREVAIL Act
  • S 1546
    Patent Eligibility Restoration Act of 2025
 Lobbying activity 5
Health Issues

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. H.R.247 - Health Care Affordability Act of 2025 S.46 - Health Care Affordability Act of 2025 H.R.1 - To provide for Reconciliation

Medicare/Medicaid

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. House Concurrent Resolution 14 - Establishing the congressional budget for the US government for FY2025. Senate Concurrent Resolution 7 - Establishing the congressional budget for the US government for FY2025. H.R.1 - To provide for Reconciliation

Taxation/Internal Revenue Code

Legislation and regulation affecting tax exempt health care entities and tax treatment of health insurance coverage and care. Extension of the enhanced Advance Premium Tax Credit (APTC) for marketplace health insurance coverage. H.R.1 - To provide for Reconciliation

Defense

Legislation and regulation affecting the TRICARE program.

Pharmacy

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.527 - Prescription Pricing for the People Act S.1040 - Drug Competition Enhancement Act S.1041 - Affordable Prescriptions for Patients Act S.1097 - Interagency Patent Coordination and Improvement Act S.1095 - Stop STALLING Act S.1096 - Preserve Access to Affordable Generics and Biosimilars Act S.1553 - PREVAIL Act S.1546 - Patent Eligibility Restoration Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem